Form 4: Director Myriam Curet Acquires Stereotaxis Stock

Director Myriam Curet acquired 43,103 restricted share units of Stereotaxis, Inc. on July 1, 2026, as part of a grant.

Summary

• Director Myriam Curet was granted 43,103 restricted share units (RSUs) of Stereotaxis, Inc. on July 1, 2026.
• Each RSU represents a right to receive one share of common stock.
• These RSUs vest on the earliest of the fifth anniversary of the award date, the director's termination of service, or a Change of Control.
• Following this grant, Curet beneficially owns 435,161 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation grant to a director rather than a significant strategic move or financial performance indicator.

Positives

• Director Myriam Curet's acquisition of restricted share units indicates continued commitment and alignment with the company's performance.
• The grant of RSUs is a common incentive for directors, aligning their interests with shareholders through potential future stock ownership.

Risks

• The vesting of RSUs is contingent on continued service, a Change of Control, or termination of service, introducing potential risks related to director retention and company stability.
• The value of the RSUs is tied to the future performance of Stereotaxis, Inc. stock, which is subject to market volatility and company-specific risks.

Future Outlook

The future outlook for the acquired restricted share units depends on the vesting conditions being met, specifically the director's continued service, the occurrence of a Change of Control, or the termination of service.

Industry Context

StockSavvy.ai notes that the issuance of restricted share units to directors is a standard practice in the medical technology sector to incentivize long-term commitment and align executive interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant aligns director interests with long-term shareholder value, but the immediate impact is dilution if RSUs are settled in stock.
• Employees: May be seen as a standard compensation practice, potentially impacting morale if perceived as inequitable.
• Management: Reinforces standard compensation practices for board members.

Next Steps

• Vesting of restricted share units based on specified conditions.
• Potential future reporting of changes in beneficial ownership as RSUs vest or are transacted.

Key Dates

Keywords

Stereotaxis, STXS, Form 4, Insider Trading, Restricted Stock Units, Director Compensation, Securities Ownership, SEC Filing